These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21897388)

  • 1. GSTPi-positive tumour microenvironment-associated fibroblasts are significantly associated with GSTPi-negative cancer cells in paired cases of primary invasive breast cancer and axillary lymph node metastases.
    Chaiwun B; Sukhamwang N; Trakultivakorn H; Saha B; Young L; Tsao-Wei D; Naritoku WY; Groshen S; Taylor CR; Imam SA
    Br J Cancer; 2011 Oct; 105(8):1224-9. PubMed ID: 21897388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.
    Shabani N; Mylonas I; Kunert-Keil C; Briese V; Janni W; Gerber B; Friese K; Jeschke U
    Anticancer Res; 2005; 25(3A):1761-4. PubMed ID: 16033096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of multidrug resistance in cell lines and primary breast tumours by flow cytometry.
    Brotherick I; Shenton BK; Egan M; Cunliffe WE; Browell DA; Lunt LG; Young JR; Higgs MJ
    Eur J Cancer; 1996 Dec; 32A(13):2334-41. PubMed ID: 9038618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Carcinoma-associated Fibroblasts Share Similar Biomarker Profiles in Matched Lymph Node Metastasis.
    Mundim FG; Pasini FS; Nonogaki S; Rocha RM; Soares FA; Brentani MM; Logullo AF
    Appl Immunohistochem Mol Morphol; 2016; 24(10):712-720. PubMed ID: 26808127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific upregulation of RHOA and RAC1 in cancer-associated fibroblasts found at primary tumor and lymph node metastatic sites in breast cancer.
    Rozenchan PB; Pasini FS; Roela RA; Katayama ML; Mundim FG; Brentani H; Lyra EC; Brentani MM
    Tumour Biol; 2015 Dec; 36(12):9589-97. PubMed ID: 26142737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer.
    Pargaonkar AS; Beissner RS; Snyder S; Speights VO
    Arch Pathol Lab Med; 2003 Jun; 127(6):701-5. PubMed ID: 12741893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of automated image analysis reduces the workload of manual screening of sentinel lymph node biopsies in breast cancer.
    Holten-Rossing H; Talman MM; Jylling AMB; Laenkholm AV; Kristensson M; Vainer B
    Histopathology; 2017 Dec; 71(6):866-873. PubMed ID: 28677240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms.
    Pelon F; Bourachot B; Kieffer Y; Magagna I; Mermet-Meillon F; Bonnet I; Costa A; Givel AM; Attieh Y; Barbazan J; Bonneau C; Fuhrmann L; Descroix S; Vignjevic D; Silberzan P; Parrini MC; Vincent-Salomon A; Mechta-Grigoriou F
    Nat Commun; 2020 Jan; 11(1):404. PubMed ID: 31964880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new perspective on axillary dissection in situations of metastatic sentinel node].
    Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
    Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Breast Tumor Strain Ratio Is a Predictive Parameter for Axillary Lymph Node Metastasis in Patients With Invasive Breast Cancer.
    Kim JY; Shin JK; Lee SH
    AJR Am J Roentgenol; 2015 Dec; 205(6):W630-8. PubMed ID: 26587952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary Skip Metastases and the False-Negative Rate of Sentinel Lymph Node Biopsy in Patients With Breast Cancer Are Related to Negative ALDH-1 Expression and Ki-67 Expression.
    Kim WG; Lee J
    Int J Surg Pathol; 2017 Aug; 25(5):397-405. PubMed ID: 28145149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary tumour burden in women with a fine-needle aspiration/core biopsy-proven positive node on ultrasonography compared to women with a positive sentinel node.
    Lloyd P; Theophilidou E; Newcombe RG; Pugh L; Goyal A
    Br J Surg; 2017 Dec; 104(13):1811-1815. PubMed ID: 28991362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer subtypes can be determinant in the decision making process to avoid surgical axillary staging: A retrospective cohort study.
    Marrazzo A; Boscaino G; Marrazzo E; Taormina P; Toesca A
    Int J Surg; 2015 Sep; 21():156-61. PubMed ID: 26253849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node metastases.
    Majid S; Rydén L; Manjer J
    BMC Cancer; 2019 Jun; 19(1):626. PubMed ID: 31238899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indium-111-octreotide scintigraphy, intraoperative gamma-detector localisation and somatostatin receptor expression in primary human breast cancer.
    Skånberg J; Ahlman H; Benjegård SA; Fjälling M; Forssell-Aronsson EB; Hashemi SH; Nilsson O; Suurkula M; Jansson S
    Breast Cancer Res Treat; 2002 Jul; 74(2):101-11. PubMed ID: 12186370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
    Weaver DL; Krag DN; Ashikaga T; Harlow SP; O'Connell M
    Cancer; 2000 Mar; 88(5):1099-107. PubMed ID: 10699901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.